GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sinclair Pharma PLC (XPAR:SPH) » Definitions » Net Change in Cash

Sinclair Pharma (XPAR:SPH) Net Change in Cash : €0.24 Mil (TTM As of Jun. 2018)


View and export this data going back to . Start your Free Trial

What is Sinclair Pharma Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Sinclair Pharma's Net Change in Cash for the six months ended in Jun. 2018 was €1.73 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2018 was €0.24 Mil.

Sinclair Pharma Net Change in Cash Historical Data

The historical data trend for Sinclair Pharma's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinclair Pharma Net Change in Cash Chart

Sinclair Pharma Annual Data
Trend Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Dec17
Net Change in Cash
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.94 1.21 15.79 -7.06 -16.83

Sinclair Pharma Semi-Annual Data
Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Jun17 Dec17 Jun18
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 85.79 -64.87 -15.43 -1.49 1.73

Sinclair Pharma Net Change in Cash Calculation

Sinclair Pharma's Net Change in Cash for the fiscal year that ended in Dec. 2017 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-12.485+-10.004+5.664+0
=-16.83

Sinclair Pharma's Net Change in Cash for the quarter that ended in Jun. 2018

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-9.566+-4.319+15.611+0
=1.73

Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2018 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.24 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sinclair Pharma Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Sinclair Pharma's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinclair Pharma (XPAR:SPH) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sinclair Pharma PLC (XPAR:SPH) » Definitions » Net Change in Cash
Comparable Companies
XKRX:016580 XKRX:001360 ROCO:6576 ROCO:6472 TPE:1720 TSXV:FLWR XKRX:003060 XKRX:102460 AVDL XKLS:7148 XMAD:RJF XCNQ:OH TSX:RIV BOM:506197 SLDB SHSE:603139 TSX:TGOD SZSE:300254 LSE:AMYT OSTO:ORX
Traded in Other Exchanges
N/A
Address
Website
http://www.sinclairispharma.com
Sinclair Pharma PLC is a United Kingdom-based specialty pharmaceutical company focused on Dermatology, in particular, Aesthetics, Wound care, and Skin care. The group has a direct sales and marketing presence in the top five European markets and a rapidly growing International division concentrated on key emerging markets through long-term multi-product, multi-country, sales & marketing and distribution deals with key strategic partners. The Company's reportable operating segments are International Operations, France, Italy, Germany, UK, and Spain.